Nature Reviews Neurology

Scope & Guideline

Empowering Minds through Cutting-edge Neurological Reviews.

Introduction

Delve into the academic richness of Nature Reviews Neurology with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1759-4758
PublisherNATURE PORTFOLIO
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2009 to 2024
AbbreviationNAT REV NEUROL / Nat. Rev. Neurol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressHEIDELBERGER PLATZ 3, BERLIN 14197, GERMANY

Aims and Scopes

Nature Reviews Neurology aims to provide comprehensive and up-to-date reviews of the latest research in neurology, encompassing a wide range of topics related to neurological disorders, their mechanisms, and potential therapies. The journal highlights innovative methodologies and interdisciplinary approaches, fostering collaboration within the field.
  1. Neurodegenerative Diseases:
    The journal consistently focuses on understanding the pathophysiology, diagnosis, and treatment of neurodegenerative diseases such as Alzheimer's disease, multiple sclerosis, and Parkinson's disease.
  2. Neuroinflammation and Immune Response:
    A significant area of research includes the role of neuroinflammation in various neurological conditions, exploring how immune responses affect disease progression and potential therapeutic targets.
  3. Biomarkers and Precision Medicine:
    There is a strong emphasis on identifying biological markers for early diagnosis and monitoring of neurological diseases, which is crucial for the emerging field of precision medicine.
  4. Therapeutic Innovations:
    The journal frequently publishes articles on novel therapeutic strategies, including gene therapy, immunotherapy, and advanced neuromodulation techniques, reflecting the shift towards more targeted and effective treatments.
  5. Public Health and Neurology:
    Nature Reviews Neurology also addresses the broader implications of neurological research in public health, including health disparities and the impact of social determinants on neurological care.
Nature Reviews Neurology is currently reflecting emerging trends in neurology research, with a focus on innovative methodologies and interdisciplinary approaches. This evolution indicates a dynamic response to new challenges in the field.
  1. Neuroimmunology:
    Research on the interplay between the nervous and immune systems is gaining traction, particularly in the context of autoimmune neurological disorders and the role of inflammation in neurodegeneration.
  2. Digital Health and Neurology:
    The integration of digital technologies in monitoring and treating neurological disorders is emerging as a significant theme, with increased emphasis on telemedicine, mobile health applications, and digital biomarkers.
  3. Microbiome and Neurological Health:
    Emerging studies exploring the gut-brain axis and the impact of the microbiome on neurological health are becoming more prominent, highlighting the complex interactions between systemic health and neurological conditions.
  4. Machine Learning and AI in Neurology:
    The application of artificial intelligence and machine learning techniques for diagnosis and treatment of neurological disorders is on the rise, indicating a shift towards data-driven approaches in clinical practice.
  5. Environmental and Genetic Interactions:
    Research focusing on the interactions between environmental factors and genetic predispositions in the development of neurological disorders is increasingly relevant, reflecting a comprehensive view of disease etiology.

Declining or Waning

While Nature Reviews Neurology has seen an expansion in various research areas, some themes appear to be losing prominence over time. This may reflect a shift in focus towards more pressing contemporary issues or advancements in research methodologies.
  1. Traditional Pharmacological Approaches:
    There has been a noticeable decline in the focus on traditional pharmacological treatments for neurological disorders, as the journal increasingly highlights innovative therapies and approaches.
  2. Basic Science Without Clinical Relevance:
    Papers that solely discuss basic science findings without a clear clinical application seem to be waning, as the journal prioritizes translational research that bridges laboratory findings with clinical practice.
  3. Epidemiological Studies:
    Although still important, the frequency of purely epidemiological studies appears to be decreasing, possibly due to a shift towards more integrated approaches that combine clinical, molecular, and epidemiological perspectives.

Similar Journals

INTERNATIONAL JOURNAL OF NEUROSCIENCE

Advancing the Frontiers of Neuroscience Knowledge
Publisher: TAYLOR & FRANCIS LTDISSN: 0020-7454Frequency: 12 issues/year

The INTERNATIONAL JOURNAL OF NEUROSCIENCE, published by TAYLOR & FRANCIS LTD, stands as a vital resource in the field of neuroscience since its inception. With a proud history of publication from 1970 to 2024, this journal is committed to advancing knowledge in various domains of neuroscience, from fundamental research to clinical applications. It is indexed with an ISSN of 0020-7454 and an E-ISSN of 1563-5279, reflecting its wide reach and recognition. The journal maintains a respectable position in the academic landscape, categorized as Q2 in Medicine (miscellaneous) and Q3 in Neuroscience (miscellaneous) as of 2023, signifying its relevance among researchers and professionals. Although it currently does not offer open access, the journal remains a significant platform for disseminating groundbreaking research, thereby fostering collaboration and innovation within the neuroscience community. Located in the United Kingdom, the journal aims to bridge gaps in neuroscience knowledge, making it an essential reading for students, professionals, and researchers dedicated to unraveling the complexities of the nervous system.

NEUROMOLECULAR MEDICINE

Illuminating the Path to Neurotherapeutic Breakthroughs
Publisher: HUMANA PRESS INCISSN: 1535-1084Frequency: 4 issues/year

NEUROMOLECULAR MEDICINE, published by HUMANA PRESS INC, is a prestigious peer-reviewed journal dedicated to advancing the fields of cellular and molecular neuroscience, molecular medicine, and neurology. With an ISSN of 1535-1084 and an E-ISSN of 1559-1174, the journal boasts a significant presence in academic research since its inception in 2002 and continues to publish cutting-edge studies through 2024. Ranked in the Q2 category for 2023 in various disciplines, including Neuroscience and Molecular Medicine, it holds impressive positions in Scopus rankings, including 41st out of 192 in Neuroscience and Neurology. Although not an open access journal, NEUROMOLECULAR MEDICINE remains invaluable for researchers, professionals, and students seeking to explore the intricate relationships between molecular mechanisms and neurological functions, thereby contributing to the scientific understanding of nervous system diseases and therapeutic innovations.

NEUROLOGICAL RESEARCH

Illuminating the Path to Neurological Innovation
Publisher: TAYLOR & FRANCIS LTDISSN: 0161-6412Frequency: 12 issues/year

NEUROLOGICAL RESEARCH, published by TAYLOR & FRANCIS LTD, is a distinguished journal focusing on the diverse and evolving field of neurology. Established in 1979, this journal has been a prominent platform for disseminating groundbreaking research and clinical advances up to 2024. With an ISSN of 0161-6412 and an E-ISSN of 1743-1328, it offers valuable insights for researchers, professionals, and students interested in the intricate workings of the nervous system. The journal holds a respectable Q2 ranking in the field of Medicine (miscellaneous) and Q3 in the categories of Neurology and Clinical Neurology, reflecting its commitment to high-quality research. Although NEUROLOGICAL RESEARCH does not currently offer an open access option, its contributions to the literature are vital for fostering advancements in neurological understanding and treatment. With an engaged readership and a mission to advance scientific knowledge, NEUROLOGICAL RESEARCH serves as a crucial resource for anyone dedicated to neurological health and innovation.

ANNALS OF NEUROLOGY

Elevating the Understanding of Neurology Since 1977
Publisher: WILEYISSN: 0364-5134Frequency: 12 issues/year

ANNALS OF NEUROLOGY, published by Wiley, stands as a leading journal in the field of neurology, renowned for its rigorous peer-reviewed articles that contribute significantly to the understanding of neurological disorders and advances in clinical practices. With an impressive impact factor and ranked Q1 in both neurology and clinical neurology categories, this journal positions itself among the top repositories of cutting-edge research, indexed in Scopus with exemplary ranks in the 98th and 97th percentiles respectively. Since its inception in 1977 and with a commitment to excellence extending to 2024 and beyond, ANNALS OF NEUROLOGY aims to disseminate groundbreaking studies and foster dialogue within the academic community, making it an essential resource for researchers, healthcare professionals, and students dedicated to neurology. Although it does not currently offer open access, its accessibility through institutional subscriptions facilitates widespread scholarly engagement.

Neurotherapeutics

Unlocking Innovative Therapies for Neurological Disorders.
Publisher: SPRINGERISSN: 1933-7213Frequency: 4 issues/year

Neurotherapeutics, published by Springer, is a leading Open Access journal dedicated to the field of neurology and pharmacology, specifically focusing on innovative therapeutic approaches for neurological disorders. With an impressive impact factor and recognized as a prestigious outlet in its domain—ranking Q1 in Neurology (Clinical) and Pharmacology—this journal serves as an invaluable resource for researchers, healthcare professionals, and students aiming to stay updated with the latest advancements in neurotherapeutics. Since its inception in 2007 and now transitioning to Open Access from 2024, Neurotherapeutics enhances accessibility to high-quality research, ensuring that critical findings reach a global audience. Its current Scopus rankings further underscore its significance, placing it within the top echelons of pharmacology and clinical neurology. By fostering a robust platform for the dissemination of pioneering research, Neurotherapeutics plays a crucial role in shaping the future of neurological treatment and care.

Neurology Research International

Empowering Neurological Discovery and Dialogue
Publisher: HINDAWI LTDISSN: 2090-1852Frequency:

Neurology Research International, published by HINDAWI LTD, is an esteemed open access journal that has been serving the neurology community since 2010. With its ISSN 2090-1852 and E-ISSN 2090-1860, this journal aims to foster knowledge dissemination and facilitate dialogue surrounding key issues in neurology and clinical neuroscience, making it a vital resource for researchers, clinicians, and students alike. It operates from the United States, with its administrative hub located in London, England. As of 2023, the journal has been positioned in the Q3 category for both neurology and clinical neurology, reflecting its commitment to advancing research within these critical fields. With a current Scopus rank of #216/400 in clinical neurology and a #113/192 in neuroscience, and a converged publication timeline from 2010 to 2024, Neurology Research International is dedicated to promoting high-quality research that addresses contemporary challenges and innovations in neurological science. By offering open access since its inception, it ensures that cutting-edge research is freely available, aligning with the global push towards accessible scientific communication.

Alzheimers Research & Therapy

Fostering collaboration to combat neurodegenerative disorders.
Publisher: BMCISSN: Frequency: 1 issue/year

Alzheimer's Research & Therapy is a leading peer-reviewed journal published by BMC, dedicated to advancing our understanding of Alzheimer's disease and other neurodegenerative disorders. As an Open Access journal since 2009, it ensures that vital research findings are freely accessible to the global community, facilitating collaboration and innovation in the field. The journal's commitment to quality is evident in its impressive impact factor and its prestigious ranking in the Q1 quartile across multiple categories including Cognitive Neuroscience and Neurology. With a Scopus rank placing it in the top tier of both Neuroscience and Neurology disciplines, Alzheimer's Research & Therapy serves as a crucial platform for researchers, clinicians, and students who seek to contribute to the fight against Alzheimer's and related disorders. The journal covers a wide range of topics and actively encourages submissions that explore therapeutic strategies and innovative research methodologies, enriching the scientific dialogue in this vital area of health.

JOURNAL OF CLINICAL NEUROSCIENCE

Exploring New Horizons in Clinical Neuroscience
Publisher: ELSEVIER SCI LTDISSN: 0967-5868Frequency: 12 issues/year

JOURNAL OF CLINICAL NEUROSCIENCE is an esteemed publication dedicated to advancing the field of neurology and related medical disciplines. Published by ELSEVIER SCI LTD, this journal serves as a vital resource for researchers, clinicians, and educators, providing a platform for the dissemination of high-quality research findings since its inception in 1994. With a noteworthy impact factor and ranked within the Q2 and Q3 categories across various medical specialties, including neurology and surgery, the journal positions itself at the forefront of clinical neuroscience. Although it operates under a traditional subscription model, the journal’s commitment to publishing rigorous scientific work ensures that it remains an integral reference for anyone involved in the diagnosis, treatment, and understanding of neurological disorders. Readers can access a diverse array of articles that not only highlight current research trends but also foster the exchange of innovative ideas in clinical practice.

MOLECULAR NEUROBIOLOGY

Illuminating Pathways in Neurobiology Research
Publisher: SPRINGERISSN: 0893-7648Frequency: 12 issues/year

Welcome to Molecular Neurobiology, the premier journal dedicated to the exploration of the molecular mechanisms underlying nervous system function and pathophysiology. Published by Springer, this journal provides an essential platform for disseminating high-quality research in the rapidly evolving fields of Cellular and Molecular Neuroscience and Neurology, boasting an impressive impact factor that reflects its esteemed position within the academic community. With its ranking in the Q1 and Q2 quartiles for various neuroscience categories, Molecular Neurobiology stands at the forefront of groundbreaking discoveries, showcasing innovative studies that bridge basic science and clinical application. Researchers and professionals are invited to contribute to its rich portfolio, which spans from fundamental insights into cellular processes to advanced therapeutic strategies. Although Molecular Neurobiology does not operate as an Open Access journal, its influential body of work remains accessible through institutional and personal subscriptions. As we converge from 1987 to 2024, we continue to aim for excellence, seeking to catalyze progress in understanding neurological diseases and enhance the scientific dialogue within the neuroscience community.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Advancing the Frontiers of Neuropathology and Neurology
Publisher: OXFORD UNIV PRESS INCISSN: 0022-3069Frequency: 12 issues/year

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, published by Oxford University Press Inc, stands as a pivotal resource for advancing research and knowledge in the domains of neuropathology and experimental neurology. Established in 1942, this esteemed journal has expanded its influence, as evidenced by its Q1 rankings in both Neurology (clinical) and Pathology and Forensic Medicine, along with its strong placement in Cellular and Molecular Neuroscience. With an emphasis on innovative research and clinical practices, it caters to a diverse audience, including researchers and clinicians dedicated to understanding neurological disorders through a multidisciplinary lens. While not open access, this journal provides access to cutting-edge studies that are pivotal in shaping the future of medical science and pathology. Researchers benefit from its rigorous peer-review process, ensuring the publication of high-caliber work that meets the evolving demands of the field.